Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyproheptadine in Schizophrenia
IRCT20100127003210N22Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jul 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cyproheptadine in schizophrenia, sponsored by Shahid Beheshti University of Medical Sciences. Started Jul 2021; status: completed.
02
Drugs
cyproheptadine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on IRCT20100127003210N22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100127003210N22.